相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Nanoparticle-based medicines in clinical cancer therapy
Shuhang Wang et al.
NANO TODAY (2022)
A COVID-19 vaccine candidate using SpyCatcher multimerization of the SARS-CoV-2 spike protein receptor-binding domain induces potent neutralising antibody responses
Tiong Kit Tan et al.
NATURE COMMUNICATIONS (2021)
Mosaic nanoparticles elicit cross-reactive immune responses to zoonotic coronaviruses in mice
Alexander A. Cohen et al.
SCIENCE (2021)
Biogenic nanoparticles as immunomodulator for tumor treatment
Keman Cheng et al.
WILEY INTERDISCIPLINARY REVIEWS-NANOMEDICINE AND NANOBIOTECHNOLOGY (2020)
Dual-Antigen-Loaded Hepatitis B Virus Core Antigen Virus-like Particles Stimulate Efficient Immunotherapy Against Melanoma
Keman Cheng et al.
ACS APPLIED MATERIALS & INTERFACES (2020)
Bioengineered Nanocage from HBc Protein for Combination Cancer Immunotherapy
Wenjun Shan et al.
NANO LETTERS (2019)
A Universal Plug-and-Display Vaccine Carrier Based on HBsAg VLP to Maximize Effective Antibody Response
Arianna Marini et al.
FRONTIERS IN IMMUNOLOGY (2019)
Improved Stable Indocyanine Green (ICG)-Mediated Cancer Optotheranostics with Naturalized Hepatitis B Core Particles
Wenjun Shan et al.
ADVANCED MATERIALS (2018)
Therapeutic applications of genetic code expansion
Yujia Huang et al.
SYNTHETIC AND SYSTEMS BIOTECHNOLOGY (2018)
Expanding and reprogramming the genetic code
Jason W. Chin
NATURE (2017)
Virus like particles as a platform for cancer vaccine development
Hui Kian Ong et al.
PEERJ (2017)
Escherichia coli-derived virus-like particles in vaccine development
Xiaofen Huang et al.
NPJ VACCINES (2017)
Construction and Immunological Evaluation of CpG-Au@HBc Virus-Like Nanoparticles as a Potential Vaccine
Yarun Wang et al.
NANOSCALE RESEARCH LETTERS (2016)
pH-responsive Virus-like Nanoparticles with Enhanced Tumour-targeting Ligands for Cancer Drug Delivery
Roya Biabanikhankahdani et al.
SCIENTIFIC REPORTS (2016)
Construction and Immunological Evaluation of CpG-Au@HBc Virus-Like Nanoparticles as a Potential Vaccine
Yarun Wang et al.
NANOSCALE RESEARCH LETTERS (2016)
Plug-and-Display: decoration of Virus-Like Particles via isopeptide bonds for modular immunization
Karl D. Brune et al.
SCIENTIFIC REPORTS (2016)
Evolution of translation machinery in recoded bacteria enables multi-site incorporation of nonstandard amino acids
Miriam Amiram et al.
NATURE BIOTECHNOLOGY (2015)
Induction of Humoral and Cell-Mediated Immune Responses by Hepatitis B Virus Epitope Displayed on the Virus-Like Particles of Prawn Nodavirus
Chean Yeah Yong et al.
APPLIED AND ENVIRONMENTAL MICROBIOLOGY (2015)
MUC1: a multifaceted oncoprotein with a key role in cancer progression
Sritama Nath et al.
TRENDS IN MOLECULAR MEDICINE (2014)
Improved characteristics and protective efficacy in an animal model of E-coli-derived recombinant double-layered rotavirus virus-like particles
Tingdong Li et al.
VACCINE (2014)
Effects of Pre-Existing Anti-Carrier Immunity and Antigenic Element Multiplicity on Efficacy of a Modular Virus-Like Particle Vaccine
Yap P. Chuan et al.
BIOTECHNOLOGY AND BIOENGINEERING (2013)
A Rationally Designed Pyrrolysyl-tRNA Synthetase Mutant with a Broad Substrate Spectrum
Yane-Shih Wang et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2012)
Nanoglue: An Alternative Way To Display Cell-Internalizing Peptide at the Spikes of Hepatitis B Virus Core Nanoparticles for Cell-Targeting Delivery
Khai Wooi Lee et al.
MOLECULAR PHARMACEUTICS (2012)
Virus like particle based strategy to elicit HIV-protective antibodies to the alpha-helic regions of gp41
C. Pastori et al.
VIROLOGY (2012)
Synthesis of Tn/T Antigen MUC1 Glycopeptide BSA Conjugates and Their Evaluation as Vaccines
Hui Cai et al.
EUROPEAN JOURNAL OF ORGANIC CHEMISTRY (2011)
Developments in virus-like particle-based vaccines for infectious diseases and cancer
Luigi Buonaguro et al.
EXPERT REVIEW OF VACCINES (2011)
Virus-like particles in vaccine development
Antonio Roldao et al.
EXPERT REVIEW OF VACCINES (2010)
Persistence of antibodies and immune memory to hepatitis B vaccine 20 years after infant vaccination in Thailand
Yong Poovorawan et al.
VACCINE (2010)
Carrier induced epitopic suppression of antibody responses induced by virus-like particles is a dynamic phenomenon caused by carrier-specific antibodies
Andrea Jegerlehner et al.
VACCINE (2010)
Vaccine delivery: a matter of size, geometry, kinetics and molecular patterns
Martin F. Bachmann et al.
NATURE REVIEWS IMMUNOLOGY (2010)
The Prioritization of Cancer Antigens: A National Cancer Institute Pilot Project for the Acceleration of Translational Research
Martin A. Cheever et al.
CLINICAL CANCER RESEARCH (2009)
Nanoparticles target distinct dendritic cell populations according to their size
Vania Manolova et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2008)
Universal influenza A M2e-HBc vaccine protects against disease even in the presence of pre-existing anti-HBc antibodies
Marina De Filette et al.
VACCINE (2008)
Virus-like particles - universal molecular toolboxes
Christine Ludwig et al.
CURRENT OPINION IN BIOTECHNOLOGY (2007)
Virus-like particles: Passport to immune recognition
Elizabeth V. L. Grgacic et al.
METHODS (2006)
Immunology of hepatitis B virus and hepatitis C virus infection
B Rehermann et al.
NATURE REVIEWS IMMUNOLOGY (2005)
Cancer vaccines: Between the idea and the reality
OJ Finn
NATURE REVIEWS IMMUNOLOGY (2003)
Addition of p-azido-L-phenylaianine to the genetic code of Escherichia coli
JW Chin et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2002)
Effect of preexisting neutralizing antibodies on the anti-tumor immune response induced by chimeric human papillomavirus virus-like particle vaccines
DM Da Silva et al.
VIROLOGY (2001)
分享论文
